PRTG Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 mai 2024 @ 22:00):

Stats
Dagens volum	174 049
Gjennomsnittsvolum	171 620
Markedsverdi	5.45M
EPS	$0 ( 2024-05-14 )
Neste inntjeningsdato	( $-0.220 ) 2024-07-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0300
ATR14	$0.00500 (1.81%)

Volum Korrelasjon

Lang: 0.21 (neutral)

Kort: -0.13 (neutral)

Signal:(61.266) Neutral

Portage Biotech Inc. Korrelasjon

10 Mest positive korrelasjoner
FFIE	0.949
EVOK	0.944
NWFL	0.939
LGVN	0.939
INVZ	0.937
GLBS	0.937
TOPS	0.936
IMMX	0.936
VVOS	0.935
BPRN	0.933

10 Mest negative korrelasjoner
INBKZ	-0.925
ADTH	-0.908
APXI	-0.905
FLXS	-0.899
BSCO	-0.898
OXSQ	-0.892
SILK	-0.887
DXJS	-0.886
ESTA	-0.879
FSEA	-0.879

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Portage Biotech Inc. Korrelasjon - Valuta/Råvare

0.34
( neutral )

0.33
( neutral )

0.00
( neutral )

-0.28
( neutral )

Portage Biotech Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-1 000.00 (0.00 %)
EPS:	$-6.49

FY	2023
Omsetning:	$0
Bruttogevinst:	$-1 000.00 (0.00 %)
EPS:	$-6.49

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.470

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.350

Financial Reports:

No articles found.

Portage Biotech Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Portage Biotech Inc.

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.